IFS

STRUCTURAL ANALYST NOTE: IFS (Intercorp Financial Services Inc.) Date: 2026-06-13

1. Structural Readiness

• Conservative Entry: $53.51
• Current Price: $54.84
• Extension: +2.5% above the conservative entry.
• Volatility Context: The ATR at the time of the breakout was 4.0% (productive), and the current ATR is 3.7% (productive). This places the stock in the historical "sweet spot" for structural quality, suggesting sufficient volatility to drive a move without the extreme risk associated with >8% ATR readings.

2. Thesis Layer

As of 2026-06-13, there is no named secular thesis attached to this setup. This is a TACTICAL, setup-led name.

The investment case is not derived from a macroeconomic secular trend (e.g., "digital banking revolution" or "infrastructure boom") explicitly named in the current data stream. Instead, the conviction must be derived entirely from the setup quality (the confirmed price structure and volatility profile) and the business fundamentals (record earnings, margin expansion, and strategic M&A) recorded in the evidence base. We judge this name on the strength of its execution and the technical confirmation of that strength, rather than a pre-existing macro narrative.

3. Business Analysis

Intercorp Financial Services Inc. (IFS) operates as a diversified financial conglomerate in Peru, providing banking, insurance, and wealth management solutions. The company functions through three primary divisions: Banking, Insurance, and Wealth Management.

Operational Highlights (Source: Earnings Transcript, 2026-05-12):

• Financial Performance: The company delivered record quarterly net income of PEN 602 million with a Return on Equity (ROE) exceeding 19%. Management has raised its year-end ROE guidance to above 17%, up from the previous expectation of "around 17%."
• Lending Dynamics: The loan book is showing positive momentum, with higher-yielding loans growing 9% year-over-year.
• Profitability Metrics: The risk-adjusted Net Interest Margin (NIM) increased by 90 basis points over the year, reaching 4.2% in the last quarter. The cost of risk remains low at 1.4%.
• Segment Growth: The small business segment was a standout performer, growing almost 30% year-over-year, with disbursements more than doubling in March alone.

Strategic Moves (Source: SEC Filing, 2026-04-24 & Earnings Transcript, 2026-05-12):

• M&A Activity: IFS and InRetail agreed to acquire in finance XP (formerly [indiscernible]) through the purchase of IXP Holding for $130 million. Effective April 1, 2026, IFS acquired 50% of IXP Holding Corp. in a joint venture with InRetail Perú Corp., which holds the remaining 50%.
• Insurance Contribution: The insurance segment, Interseguro, reported a net profit of S/274.5 million (IFRS) for the year ended December 31, 2025. This is expected to result in a dividend payment of S/160.0 million to IFS in 2026.
• Retail Ecosystem: The company maintains a controlling stake in Intercorp Retail, which operates supermarket chains (Plaza Vea, Vivanda, MASS, Makro) and pharmacy chains (Inkafarma, MiFarma), creating a cross-selling ecosystem for financial products.

Regulatory Context: The company operates under Law No. 31143, which caps interest rates for consumers and small businesses. However, management's ability to grow higher-yielding loans and expand NIM suggests effective navigation of these regulatory constraints.

4. Archetype and Conviction

Archetype: Quality Compounder

Rationale: The name fits the "Quality Compounder" archetype based on the convergence of high profitability metrics, consistent growth, and strategic capital allocation.

• Margin Inflector: The 90 bps expansion in risk-adjusted NIM to 4.2% and the record ROE of >19% demonstrate a company actively improving its capital efficiency and pricing power.
• Growth Leader: The 30% growth in small business loans and 9% growth in higher-yielding loans indicate a successful execution of a growth strategy within a regulated environment.
• Structural Quality: The ATR readings (4.0% at breakout, 3.7% current) confirm the stock is in the "productive" bucket, indicating healthy volatility that supports trend continuation without the erratic behavior of distressed assets.

Valuation Context: The financial spine indicates a forward consensus EPS of 19.11 for FY1 and 21.74 for FY2. Recent news (2026-06-17) highlights IFS on PEG-based value screens and Zacks Rank #1 lists for both momentum and income, suggesting the market is currently pricing the stock as undervalued relative to its growth and income potential.

Conviction Stack:

• Thesis Strength: Moderate (Tactical/Setup-led, no macro thesis).
• Evidence Quality: High (Record earnings, specific M&A details, raised guidance).
• Structural Quality: High (Confirmed breakout, productive ATR).
• Setup Readiness: High (Actionable, +2.5% extension).
• Rerating Potential: Moderate to High (Driven by the raised ROE guidance and successful integration of the IXP Holding JV).

5. Invalidation, Strengthening, and Gaps

Invalidation Triggers:

• Fundamental Deterioration: A significant widening of the cost of risk above 1.4% or a contraction in the NIM below 4.0% would contradict the "Quality Compounder" narrative.
• Regulatory Shock: Any unexpected tightening of Law No. 31143 that severely compresses margins beyond current expectations.

Strengthening Factors:

• Continued Momentum: Sustained growth in the small business segment (currently +30% YoY) and successful integration of the IXP Holding JV.
• Dividend Realization: The actual receipt of the S/160.0 million dividend from Interseguro in 2026, confirming the insurance segment's cash generation.
• Guidance Beat: Management delivering on the "above 17%" ROE target for year-end 2026.

Evidence Gaps:

• Macro Sensitivity: While the company operates in Peru, there is no specific evidence in the current dataset regarding the impact of broader Peruvian macroeconomic variables (e.g., currency fluctuation, inflation rates) on the specific loan book performance beyond the regulatory caps.
• JV Synergy Details: The specific synergies or immediate revenue impact of the IXP Holding acquisition (completed April 2026) are not yet quantified in the earnings transcript beyond the acquisition price.
• Long-term Capex: No specific data on future capital expenditure plans for the retail or banking segments beyond the current acquisition.

PRIVATE ANALYST CALL

Judgment: Buy Confidence: high Key evidence: Record quarterly net income of PEN 602 million with ROE above 19%; confirmed price-breakout structure with productive ATR of 3.7%; raised year-end ROE guidance to above 17% and successful acquisition of IXP Holding for $130 million. Key risks: Regulatory interest rate caps under Law No. 31143 limiting pricing power; potential integration risks in the IXP Holding joint venture; macroeconomic volatility in Peru affecting loan demand. Sizing hint: Standard position sizing for a confirmed breakout in a quality compounder archetype; monitor ATR for volatility adjustments. Expected path: Management expectations of sustained loan growth and margin expansion should drive continued price appreciation as the market re-rates the stock based on the raised ROE guidance and earnings momentum.